동화약품 Stock: price and insider trades · South Korea
동화약품: what insiders have been doing
Every trade that managers of 동화약품 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. 2 insiders have disclosed 2 filings since 1 November 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 2 filings here.
There has been no open-market purchase by an insider of 동화약품 for at least a year.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- ●Executives0DART
- 0KRXDART:20260212001683
- ●Executives0DART
- 0KRXDART:20240814004250
- ●Executives0DART
- 0KRXDART:20230823000428
- ●Executives0DART
- ●Executives0DART
- 0KRXDART:20220930000503
- ShareKRXDART:20220930000450
- ShareKRXDART:20220930000361
- 0KRXDART:20220823000301
- 0KRXDART:20220513000862
- 0KRXDART:20220513000918
- 0KRXDART:20220513000901
- 0KRXDART:20220513000881
- 0KRXDART:20220513000810
- 0KRXDART:20220513000830
- ●Executives0DART
- ●Executives0DART
- 0KRXDART:20210831000538
- ●Executives0DART
23 of 23 declarations
About 동화약품
Dongwha Pharmaceutical is a South Korean company specializing in the healthcare and pharmaceutical sector. It is listed on the XKRX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
